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ABSTRACT 
Magnesium contributes to the regulation of inflammatory responses. Here we focus on the role of 
magnesium in acute inflammation. Although present knowledge is incomplete to delineate an 
accurate scenario and a schedule of the events occurring under magnesium deficiency, it emerges 
that low magnesium and, to some instances, its transporters favor the induction of acute 
inflammation by sensitizing sentinel cells to sense the noxious agent, and then by participating to 
the orchestration of the vascular and cellular events that characterize the process.  
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INTRODUCTION 
Inflammation has been observed since the beginning of documented medical knowledge [1], but the 
disclosure of its significance and complexity is rather recent. It is now clear that inflammation is the 
automatic response of living tissues to damage. Through a series of interconnected events involving 
blood vessels and leukocytes, it defends from damages and paves the way to the repair of injured 
tissues and organs. Inflammation is activated by the release of chemical mediators that induce 
vascular and cellular events with the objective to recruit inflammatory cells, and in particular innate 
immune cells such as neutrophils and macrophages. These cells, in turn, phagocytize the noxious 
agent and produce additional chemical mediators that eventually lead to the activation of the 
adaptive immune response.  
A link between inflammation and magnesium deficiency has been established long ago [2]. 
Magnesium (Mg) is an essential cation, which maintains vital cellular functions, since it is involved 
in all major cellular processes, including the regulation of energy metabolism, metabolic cycles and 
signaling pathways [3]. Also Mg transporters are part of a large array of physiological and 
pathological processes, including the regulation of immune response [3-7]. TRPM7, which 
possesses an ion transport domain and an active kinase domain and is responsible for cellular Mg 
homeostasis, phosphorylates phospholipase Cγ2, crucial in intracellular signaling after the 
activation of B lymphocyte, and is implicated in T cell migration [7,8]. MAGT1, a highly selective 
transporter for Mg, has a key role in T cell-mediated immune responses [9].  
 
MAGNESIUM DEFICIENCY AND ACUTE INFLAMMATION  
Mg deficiency impairs adaptive immune response, while it induces inflammation in vivo and in 
vitro [10]. In rodents, a severely Mg-restricted diet rapidly results in a dramatic drop of magnesemia 
which leads to characteristic inflammatory responses, such as hyperemia and edema, accompanied 
by leukocytosis and a significant increase of the plasma levels of interleukin (IL)-6 and acute phase 
proteins, including complement component C3 [11,12]. These events correlate with an impaired 
redox capacity characterized by a substantial increase in thiobarbituric acid-reactive substances 
associated with a significant reduction of the activity of superoxide dismutase and catalase [13]. 
Moreover, Mg deficiency reduces the synthesis of anti-oxidant glutathione, a reaction which is Mg 
dependent [14]. Short-term Mg deficiency induces also de novo synthesis of ceramide, which 
activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), the master 
regulator of inflammation, and induce the release of some inflammatory cytokines and chemokines 
[15]. 
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Experimentally induced hypomagnesemia is associated with altered calcium (Ca) homeostasis [16]. 
To this purpose, it is noteworthy that Mg is considered the natural Ca antagonist [17] and, 
accordingly, Ca deficiency attenuates the pro-inflammatory effects of dietary Mg restriction [16, 
18]. Moreover, circulating substance P, a pro-inflammatory neuropeptide, increases early in 
experimental dietary Mg deficiency. Substance P as well as other mediators contribute to induce the 
production of reactive oxygen and nitrogen species, which ultimately promote inflammation [19]. 
Since a link exists between inflammation and the composition of the microbiota, which educates the 
immune system [20], it is noteworthy that a Mg deficient diet is associated with a lower content of 
bifidobacteria in the intestine, an impairment of gut barrier and high levels of tumor necrosis factor 
(TNF)α and IL-6 mRNA in the liver and intestine. After 21 days of such a dietetic regimen, the 
bifidobacteria content increases, the performance of the intestinal barrier is restored and 
inflammation declines [21]. These findings suggest that a dynamic adaptive response occurs in 
animals fed a Mg poor diet. 
On these bases, several mechanisms seem to be involved in Mg deficiency induction of 
inflammation: i) an altered symbiotic relationship of the host with the gut microbiota; ii) oxidative 
stress generated by the excessive production of free radicals; iii) the activation of  neurogenic 
inflammation; and iv) an imbalance Ca/Mg (figure 1). 
On the other hand, under stressful conditions, and inflammation certainly is a stress [22], the 
concentrations of magnesium decrease [23]. Recently, a reduction of Mg has been described in 
acutely inflamed tissues and this is caused by the activation of the IL-33/ST2 axis [24]. These 
results suggest that a decrease of Mg concentrations in the inflammatory site is secondary to 
inflammation itself and might contribute to the exacerbation of inflammatory response to immune 
challenge in Mg deficient animals. Indeed, a poor Mg diet increases the vulnerability to 
lipopolysaccharide (LPS) in vivo and enhances the response of neutrophils and macrophages ex vivo 
[25]. That Mg is directly implicated in this hypersensitivity to LPS is demonstrated by the 
prevention of these effects with Mg supplementation. In Mg-deficient animals the addition of 
magnesium before endotoxin significantly increases survival and lowers plasma values TNFα [26]. 
We will here summarize the involvement of Mg deficiency in the principal steps of acute 
inflammation, i.e. the recognition of the noxious agent, the delivery of leukocytes to the damaged 
tissue to eliminate it and the termination of the process.  
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MAGNESIUM DEFICIENCY AND ACUTE INFLAMMATION: SENSING THE DAMAGE 
If inflammation is due to external pathogens invading a tissue, two sets of signals trigger the whole 
process. The first one sparks from the pathogen itself; the second one originates from the cells that 
have been damaged. In the case of sterile inflammation, the signals that alert the organism are 
endogenous and derive from the injured cells. Sentinel cells in the tissues. i.e. mast cells, dendritic 
cells and fibroblasts, perceive the offending agent and then alert neighbor cells, thus initiating 
inflammation.  Mast cells are very abundant in the skin and in the mucosal tissues where they 
represent a first line of defense against external insults. In rats, Mg deficiency increases the 
degranulation of mast cells [27]. Since Mg antagonizes Ca [17], Mg deficiency rises cytosolic Ca, 
which facilitates degranulation by destabilizing membranes and activating trimeric G proteins [28-
29]. It is interesting to note that mice heterozygous for a TRPM7 kinase deletion are 
hypomagnesemic and hyperallergic [30], thus mimicking the phenotype of animals fed a low Mg 
diet. Therefore, the kinase domain of TRPM7 assures proper Ca-induced exocytosis and regulates 
the Ca and Mg sensitivity of G protein-coupled receptor-mediated mast cell degranulation by 
modifying granular mobility and/or histamine content. Also dendritic cells are present in tissues that 
are in contact with the external environment where they sample the surrounding environment for 
pathogens [31]. If activated by the recognition of a pathogen, dendritic cells engulf and process it, 
and migrate to the regional lymph nodes where they present the antigen to T lymphocytes, thereby 
shaping immune response. Mg deficiency does not significantly impact on dendritic cell function in 
a model of co-culture with lymphocytes [32]. However, it is known that high extracellular Mg 
significantly suppresses the antigen-presenting capacity of the Langerhans cells, because it reduces 
expression of HLA-DR and costimulatory B7 molecules by the dendritic cells [33]. To our 
knowledge, no data are available about Mg and its transporters on the function of fibroblasts. Since 
injury and mechanical stress induce the release from fibroblasts of biologically active IL-33 [34], 
which acts as an alarmin, it would be interesting to evaluate whether Mg deficiency modulates IL-
33 release in these cells. In general, studies about the effects of low Mg on fibroblasts should be 
fostered, since these cells respond to tissue injury by conditioning the production of cytokines and 
the recruitment of leukocytes in areas of inflammation [35].  
 
MAGNESIUM DEFICIENCY AND ACUTE INFLAMMATION: THE VASCULAR EVENTS 
Important vascular events characterize the early phases of acute inflammation. Vasodilation leads to 
an increase of blood flow, and is quickly followed by the raise of capillary permeability, with the 
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aim of boosting the accumulation of plasma proteins in the site of damage. These events are driven 
by the interconnected action of several mediators, initially vasoactive amines and then lipid 
products. In the beginning, histamine locally released by mast cells induces a rapid vasodilation and 
augments endothelial permeability producing intra-endothelial gaps. As mentioned above, Mg 
deficiency facilitates the degranulation of mast cells and, therefore, the release of preformed 
mediators, among which histamine. Meanwhile, mast cells, endothelial cells and other cell types 
present in the site of inflammation begin to synthesize prostaglandins and prostacyclin, vasodilators 
and vaso-permeabilizing agents, via cyclooxygenase. Also leukotrienes, which increase endothelial 
permeability, begin to be produced via lipoxygenase. Magnesium availability modulates the 
synthesis of several of these mediators (figure 2). The biosynthesis of eicosanoids, mainly 
prostacyclin, is stimulated in Mg deficiency [36,37]. Accordingly, magnesium suppresses the 
activation of phospholipase A2 and the production of arachidonate metabolites in macrophages [38] 
and inhibits lipoxygenase activity in human leukocytes [39]. Moreover, Mg deficiency induces the 
production of platelet activating factor, a vasodilator and vaso-permeabilizing factor [40] and the 
synthesis of nitric oxide, another potent inflammatory mediator which induces vascular 
permeability. In the plasma of Mg-deficient rats high concentration of nitric oxide were found 
because of the activation of inducible oxide synthase [41]. 
Endothelial cells are crucial in orchestrating the vascular reactions of acute inflammation. They 
secrete various molecules mediating vasodilatation and permeabilization such as prostacyclin and 
nitric oxide, and release cytokines and chemokines that facilitate the recruitment of leukocytes. In 
response to low extracellular Mg, cultured microvascular endothelial cells activate NF-kB, which 
induces the expression of a large array of pro-inflammatory proteins [42]. Mg deficiency 
upregulates cell-surface adhesion molecules, which renders the endothelium adhesive for 
leukocytes [43], and the chemokines IL-8 and monocyte chemoattractant protein-1 (MCP-1/CCL2) [42]. 
IL-8 attracts neutrophils, which predominate in the inflammatory infiltrate during the early phases, 
and stimulates their degranulation with the consequent release of various enzymes that may 
contribute to tissue damage. MCP-1 is a potent chemotactic factor for many inflammatory cells 
including monocytes and T cells, which accumulate in the late phase of inflammation. Also C-
Reactive Protein (CRP), a modulator of innate immunity and an marker of inflammation which 
increases in Mg deficiency [11,44], exerts potent pro-inflammatory actions on  endothelial cells, i.e. 
by inducing the expression of adhesion molecules [45]. It is likely that high levels of CRP 
cooperates with Mg deficiency to activate endothelial cells.  
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MAGNESIUM DEFICIENCY AND ACUTE INFLAMMATION: THE CELLULAR  EVENTS 
Once attached to the endothelium, the leukocytes transmigrate, pierce the basal membrane by 
secreting metalloproteases and accumulate in extravascular sites. While no direct data are available 
about the effects of Mg on leukocyte transmigration, it is reported that low Mg induces the 
synthesis and the activity of metalloproteases [46], which facilitates the entry in the inflamed 
tissues. After exiting the blood, leukocytes migrate following the chemical gradient generated by 
locally produced chemoattractants, among which leukotrienes, chemokines and components of the 
complement system. In the site of injury, leukocytes are functional for eliminating the offending 
agents. In particular, the leukocytes capable of phagocytosis - neutrophils and macrophages - are the 
principal players, since they ingest and destroy microbes, foreign substances and necrotic tissues. 
The activation of these cells is triggered by elevation of intracellular Ca with the consequent 
involvement of phospholipase A2 and protein Kinase C. Since low extracellular Mg concentration 
leads to the increase of intracellular Ca and the activation of protein kinase C [47], it is not 
surprising that neutrophils and macrophages isolated from Mg deficient rats show higher 
phagocytosis than control animals [48]. However, extracellular Mg concentration has no significant 
impact on phagocytosis of cultured bone marrow-derived antigen-presenting cells [32]. The 
discrepancy between ex vivo and in vitro results might be ascribed to the systemic response that 
accompanies Mg deficiency, namely  the activation of the hypothalamo-pituitary adrenal cortex axis 
and the renin-angiotensin-aldosteron system, both contributing to alterations of the immune 
response, as well as the increased plasma levels of substance P and cytokines, which are important 
priming agents [49]. Because killing of microbes is accomplished by reactive oxygen species 
(ROS), it is noteworthy that phagocytes from Mg deficient rats produce more ROS under basal 
conditions and are hyper-responsive to immune challenge when compared to control animals [26, 
48]. Remarkably, human neutrophils from healthy donors incubated in low Mg concentration 
showed an increased respiratory burst in response to activating agents than controls in normal Mg 
concentration [50]. 
 
MAGNESIUM DEFICIENCY AND ACUTE INFLAMMATION: THE RESOLUTION  
When no longer needed, inflammation is actively terminated to prevent unnecessary damage to 
tissues and restore their integrity and function. Resolution begins early through the coordinated 
synthesis of various anti-inflammatory mediators, among which IL-10, transforming growth factor 
(TGF)β, and pro-resolving lipid mediators such as lipoxins, resolvins and maresins [51]. Even 
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though little is known about the contribution of Mg to this process, some evidence is available that 
supports that Mg deficiency also has anti-inflammatory actions. By increasing the synthesis of 
metalloproteases [46], which cleave chemokines, low Mg reduces the infiltration of leukocytes. 
Moreover, cells cultured in low extracellular Mg produce high levels of IL-10 [47], which represses 
pro-inflammatory responses and limits unnecessary tissue disruptions. In microvascular endothelial 
cells, low extracellular Mg rapidly activates NF-kB partly through the overproduction of ROS, but 
later it also activates peroxisome proliferator-activated receptor (PPAR)γ [42], probably through the 
induction of eicosanoids. PPARγ inhibits NF-kB by complexing with NF-kB subunits and shuttling 
them from the nucleus to the cytoplasm [42]. We argue that the activation of PPARγ in low Mg tips 
the balance towards the resolution of inflammation (figure 3). Turning our attention to Mg 
transporters, it is noteworthy that TRPM7 channel activity is implicated in macrophage polarization 
towards the anti-inflammatory M2 phenotype [52]. 
 
CONCLUSIONS 
From the studies in vivo, ex vivo and in vitro, it is clear that, under Mg deficiency, pro-inflammatory 
events predominate over its anti-inflammatory actions. Accordingly, physiologic or high 
extracellular concentrations of Mg exert anti-inflammatory properties. In cultured endothelial cells 
high Mg inhibits NF-kB and prevents the release of inflammatory mediators and cytokines [42], 
while in neutrophils and macrophages Mg inhibits oxidative burst [53,54]. Moreover, high 
extracellular Mg reduces the release of inflammatory cytokines from leukocytes [55] and the levels 
of Toll-like receptor (TLR) 4 in sebocytes [56]. Short-term exposure to Mg in vitro substantially 
reduced the frequency of neonatal monocytes producing TNF-α and IL-6 under constitutive and 
TLR-stimulated conditions, without influencing cell viability or phagocytic function. Upon TLR 
stimulation, Mg anti-inflammatory properties are due to the inhibition of NF-kB activation through 
the increase of IkBα levels [57]. It is likely that many of the effects of high Mg are due to its 
antagonisms with Ca and to its anti-oxidant action. Recently, Chandrasekaran and colleagues 
proposed a novel potential mechanism by which Mg inhibits inflammation. Mg could be involved 
in the activation of the thiamine pyrophosphate-dependent riboswitch, resulting in the increased 
synthesis from thiazole pyrophosphate of thiazole, which inhibits cyclooxygenase and hinders the 
formation of prostanoids [58]. 
This review underscores that there are many questions still open and highlights the need for more 
research to delineate a clear picture of how Mg, its transporters and sensors contribute to the 
modulation of acute inflammation. 
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FIGURES 
 
Figure 1. Possible mechanisms implicated in low-Mg related inflammation.  
 
Figure 2. The modulation of the synthesis of eicosanoids by Mg deficiency. 
10 
 
 
Figure 3. A summary of pro- and anti-inflammatory actions of Mg deficiency. 
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